Position in GILD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,704,794
+$29,050 QoQ
Shares Held
29,324
+11.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.55%
of 13F equity value
Holder Rank
#656
of 2,265 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ranch Capital Advisors Inc. holds $19,506,059 across 8 Drug Manufacturers - General names. GILD ranks #4 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,434 | $4,427,712 | |
| 2 | AMGN |
Amgen Inc
|
12,108 | $4,384,548 | |
| 3 | ABBV |
AbbVie Inc.
|
16,101 | $4,051,655 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
29,324 | $3,704,794 | |
| 5 | PFE |
Pfizer Inc
|
85,339 | $2,054,963 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,727 | $329,989 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,404 | $308,914 | |
| 8 | LLY |
ELI LILLY & Co
|
203 | $243,484 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,704,794 | 29,324 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,675,744 | 26,374 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,060,030 | 24,931 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,632,476 | 23,716 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,479,607 | 22,365 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,357,756 | 21,042 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,806,295 | 19,555 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,039,783 | 12,402 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $789,358 | 11,505 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $837,320 | 11,431 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $908,608 | 11,216 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,176,932 | 15,705 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,184,103 | 15,364 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,281,056 | 15,440 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,283,028 | 14,945 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,174,762 | 19,043 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,156,650 | 18,713 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $985,502 | 16,577 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $753,982 | 10,384 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $714,844 | 10,234 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $20,864 | 303 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $23,913 | 370 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $36,237 | 622 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $39,051 | 618 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $47,318 | 615 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $171,873 | 2,299 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||